Frontiers Spring 2011
Reasons to Celebrate: Quality indicators continue to rise
Last year, a panel of NCI experts arrived at the OSUCCC to look under the hood and see how we’re doing. I’m pleased to report that they liked what they saw. Following that visit and a review of our core-grant renewal proposal, the NCI rated our program “exceptional,” their highest descriptor, and recommended continued funding. The amount will be announced early this year.
The renewal enables Ohio State to retain its status as one of only 40 NCI-designated comprehensive cancer centers, a designation that the University has maintained since 1976. The NCI site review team also stated, “This Center should serve as the model for other matrix university-based Centers.”
These remarkable outcomes were, of course, a team effort. They were achieved through the dedication, cooperation and collaboration of our physicians, nurses, investigators and support staff.
Over the past five years, our NCI grant funding has grown by 96 percent, placing the OSUCCC 14th in annual NCI research funding nationally. Our goal is to break into the top 10. During the same period, our investigator-initiated therapeutic clinical trials jumped 258 percent, to 552, and we produced about 4,000 scientific publications. Half of those publications represent collaborations among disciplines— an amazing statistic that shows our investigators are working together to produce the best results.
Speaking of best results, the Leapfrog Group, a coalition of public and private purchasers of employee health coverage that works to improve healthcare quality, has again included the OSUCCC – James on its list of 65 “top hospitals.” The selection comes from the organization’s national survey of hospital performance in key areas of patient safety and quality.
Finally, the second annual Pelotonia, our grassroots bicycle tour held in August, generated $7.8 million exclusively for cancer research at the OSUCCC – James. The event attracted 4,047 riders, nearly double the number who participated in the 2009 inaugural Pelotonia. Together, the two events raised more than $12 million for cancer research here at home. We truly have reasons to celebrate.